Zacks is bullish on Cytori and the company's Celution System. As a result, they have given the stock a $8.00 price target. I originally covered the company in June when Zack's ran a small piece on the Celution System and gave the company a $16 price target in 2012.
I would invest with caution here since the Celution System is in its early stages and this is a young company. However it is worth pointing out that Zacks has been bullish on this company for a while and this is not a ObamaStemCellBanJumpOnTheBandwagon pick.